What is Kulicke and Soffa Industries' operating income?

Kulicke and Soffa Industries' total operating income in 2025 was -$3.22 million, based on the following breakdown: Total Gross Profit: $277.92 million Total Operating Expenses: $281.15 million

Kulicke and Soffa Industries (KLIC) Financials

$83.14 +1.22 (+1.49%)

Closing price 04:00 PM Eastern

Extended Trading

$82.30 -0.84 (-1.01%)

As of 07:54 PM Eastern

Compare

Annual Income Statements for Kulicke and Soffa Industries

This table shows Kulicke and Soffa Industries' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	10/4/2025
Net Income / (Loss) Attributable to Common Shareholders	52	48	126	57	12	52	367	434	57	-69	0.21
Consolidated Net Income / (Loss)	52	48	126	57	12	52	367	434	57	-69	0.21
Net Income / (Loss) Continuing Operations	52	48	126	57	12	52	367	434	57	-69	0.21
Total Pre-Tax Income	39	56	119	178	35	64	415	477	72	-58	20
Total Operating Income	39	54	113	167	22	59	412	470	39	-92	-3.22
Total Gross Profit	252	281	382	409	255	298	697	748	359	269	278
Total Revenue	536	627	809	889	540	623	1,518	1,504	742	706	654
Operating Revenue	536	627	809	889	540	623	1,518	1,504	742	706	654
Total Cost of Revenue	285	346	427	480	285	325	821	755	384	437	376
Operating Cost of Revenue	285	346	427	480	285	325	821	755	384	437	376
Total Operating Expenses	213	227	269	243	233	239	285	278	319	361	281
Selling, General & Admin Expense	123	135	134	123	117	116	147	140	153	166	168
Research & Development Expense	90	92	100	120	116	123	137	137	145	151	150
Impairment Charge	0.00	0.00	35	-	-	-	0.00	1.35	22	44	40
Other Special Charges / (Income)	-	-	-	-	-	-	-	-	0.00	0.00	-76
Total Other Income / (Expense), net	0.45	2.21	5.43	11	13	5.83	2.10	7.12	33	34	24
Interest Expense	1.18	1.11	1.06	1.05	2.06	1.72	0.22	-	0.14	0.09	0.13
Interest & Investment Income	1.64	3.32	6.49	12	15	7.54	2.32	7.12	33	34	24
Income Tax Expense	-13	7.71	-7.39	121	23	12	47	43	15	11	20
Basic Earnings per Share	$0.69	$0.69	$1.78	$0.82	$0.18	$0.83	$5.92	$7.21	$1.01	($1.24)	$0.00
Weighted Average Basic Shares Outstanding	75.41M	70.48M	70.91M	69.38M	65.29M	62.83M	62.01M	60.16M	56.68M	55.61M	52.96M
Diluted Earnings per Share	$0.69	$0.68	$1.75	$0.80	$0.18	$0.83	$5.78	$7.09	$0.99	($1.24)	$0.00
Weighted Average Diluted Shares Outstanding	75.66M	70.84M	72.06M	70.42M	65.95M	63.36M	63.52M	61.18M	57.55M	55.61M	53.19M
Weighted Average Basic & Diluted Shares Outstanding	75.60M	70.30M	70.80M	69.10M	63.03M	62.03M	62.42M	57.02M	56.72M	53.87M	52.36M
Cash Dividends to Common per Share	-	$0.00	$0.00	$0.24	$0.48	$0.48	$0.56	-	$0.19	$0.80	$0.82

This table shows Kulicke and Soffa Industries' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	10/4/2025	1/3/2026	4/4/2026	7/4/2026
Net Income / (Loss) Attributable to Common Shareholders	9.29	-103	12	12	82	-85	-3.29	6.38	17	35	57
Consolidated Net Income / (Loss)	9.29	-103	12	12	82	-85	-3.29	6.38	17	35	57
Net Income / (Loss) Continuing Operations	9.29	-103	12	12	82	-85	-3.29	6.38	17	35	57
Total Pre-Tax Income	12	-96	16	10	93	-79	-0.12	6.70	23	43	73
Total Operating Income	1.69	-105	8.28	2.69	87	-85	-6.09	0.89	18	39	68
Total Gross Profit	80	16	85	88	87	40	69	81	99	120	158
Total Revenue	171	172	182	181	166	162	148	178	200	243	330
Operating Revenue	171	172	182	181	166	162	148	178	200	243	330
Total Cost of Revenue	91	156	97	94	79	122	79	96	101	123	172
Operating Cost of Revenue	91	156	97	94	79	122	79	96	101	123	172
Total Operating Expenses	78	122	76	85	0.87	125	75	80	81	81	90
Selling, General & Admin Expense	41	39	39	46	39	48	40	41	41	43	46
Research & Development Expense	37	38	38	39	38	37	36	39	40	38	44
Impairment Charge	-	44	0.00	-	-	40	0.00	-	-	0.00	0.00
Other Special Charges / (Income)	0.00	0.00	0.00	-	-76	0.00	0.00	-	0.00	0.00	0.00
Total Other Income / (Expense), net	9.88	8.85	8.06	7.46	6.33	5.59	5.98	5.78	4.72	3.94	4.50
Interest Expense	0.02	-	-	-	0.03	0.04	0.03	-	0.04	0.04	0.03
Interest & Investment Income	9.90	8.85	8.06	7.42	6.35	5.62	6.01	5.85	4.76	3.98	4.53
Income Tax Expense	2.28	6.36	4.05	-2.03	11	5.44	3.17	0.32	5.74	7.36	15
Basic Earnings per Share	$0.16	($1.83)	$0.22	$0.21	$1.52	($1.59)	($0.06)	$0.13	$0.32	$0.67	$1.10
Weighted Average Basic Shares Outstanding	56.65M	56.15M	55.28M	55.61M	53.79M	53.31M	52.69M	52.96M	52.32M	52.33M	52.33M
Diluted Earnings per Share	$0.16	($1.83)	$0.22	$0.21	$1.51	($1.59)	($0.06)	$0.14	$0.32	$0.66	$1.07
Weighted Average Diluted Shares Outstanding	57.02M	56.15M	55.72M	55.61M	54.21M	53.31M	52.69M	53.19M	52.52M	53.12M	53.43M
Weighted Average Basic & Diluted Shares Outstanding	56.34M	55.46M	54.51M	53.87M	53.38M	52.77M	52.15M	52.36M	52.33M	52.33M	52.33M

This table details how cash moves in and out of Kulicke and Soffa Industries' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	10/4/2025
Net Change in Cash & Equivalents	-89	-75	-31	-72	43	-176	175	193	-26	-302	-11
Net Cash From Operating Activities	88	68	136	123	66	94	300	390	173	31	114
Net Cash From Continuing Operating Activities	88	68	136	123	66	94	300	390	173	31	114
Net Income / (Loss) Continuing Operations	52	48	126	57	12	52	367	434	57	-69	0.21
Consolidated Net Income / (Loss)	52	48	126	57	12	52	367	434	57	-69	0.21
Depreciation Expense	19	16	16	19	20	20	20	21	29	25	18
Non-Cash Adjustments To Reconcile Net Income	8.73	13	62	14	14	16	11	9.94	49	143	101
Changes in Operating Assets and Liabilities, net	8.27	-9.75	-68	33	20	6.37	-98	-75	38	-68	-5.81
Net Cash From Investing Activities	-94	-129	-145	-97	47	-126	-82	134	-91	-139	28
Net Cash From Continuing Investing Activities	-94	-129	-145	-97	47	-126	-82	134	-91	-139	28
Purchase of Property, Plant & Equipment	-10	-6.22	-26	-20	-12	-12	-23	-23	-44	-16	-17
Acquisitions	-93	0.00	-28	0.00	-5.00	-1.29	-26	-0.40	-37	0.00	0.00
Purchase of Investments	-1.63	-124	-305	-684	-619	-442	-507	-469	-595	-690	-595
Sale of Property, Plant & Equipment	0.18	1.05	1.35	0.63	0.21	0.05	0.29	0.18	0.59	0.03	0.21
Divestitures	-	-	-	-	0.00	0.00	2.12	-	0.00	0.00	2.54
Sale and/or Maturity of Investments	11	0.00	213	607	683	329	472	626	585	570	640
Other Investing Activities, net	0.00	-	-	-	-	-	-	-	-0.64	-2.38	-2.88
Net Cash From Financing Activities	-84	-14	-23	-99	-71	-146	-44	-321	-112	-196	-153
Net Cash From Continuing Financing Activities	-84	-14	-23	-99	-71	-146	-44	-321	-112	-196	-153
Repurchase of Preferred Equity	-	-	-	-	-	-	-	-	0.00	-0.58	-0.33
Repurchase of Common Equity	-76	-15	-18	-90	-100	-55	-10	-281	-69	-151	-97
Payment of Dividends	-	0.00	0.00	-8.18	-32	-30	-33	-39	-42	-44	-54
Other Financing Activities, net	1.23	0.61	-3.88	0.06	0.01	-0.12	-0.38	-0.51	-0.63	-0.56	-1.57
Effect of Exchange Rate Changes	1.33	0.54	0.08	0.72	0.92	1.30	0.59	-10	3.68	1.31	0.41
Cash Interest Paid	1.18	1.11	1.06	1.05	1.63	1.72	0.22	0.21	0.14	0.09	0.13
Cash Income Taxes Paid	5.19	10	8.28	13	22	13	52	50	56	23	24

This table details how cash moves in and out of Kulicke and Soffa Industries' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	10/4/2025	1/3/2026	4/4/2026	7/4/2026
Net Change in Cash & Equivalents	-105	-65	7.17	-140	51	8.19	-40	-31	66	56	31
Net Cash From Operating Activities	-7.33	-20	27	32	19	80	7.38	7.41	-8.93	10	45
Net Cash From Continuing Operating Activities	-7.33	-20	27	32	19	80	7.38	7.41	-8.93	10	45
Net Income / (Loss) Continuing Operations	9.29	-103	12	12	82	-85	-3.29	6.38	17	35	57
Consolidated Net Income / (Loss)	9.29	-103	12	12	82	-85	-3.29	6.38	17	35	57
Depreciation Expense	7.99	6.97	4.94	4.84	5.01	5.01	3.92	4.03	3.96	3.98	4.00
Non-Cash Adjustments To Reconcile Net Income	13	113	9.87	7.72	1.39	78	11	11	8.28	7.33	11
Changes in Operating Assets and Liabilities, net	-38	-37	-0.18	6.94	-69	82	-4.61	-14	-38	-36	-27
Net Cash From Investing Activities	-61	3.43	37	-118	82	-38	-17	1.50	93	45	-3.71
Net Cash From Continuing Investing Activities	-61	3.43	37	-118	82	-38	-17	1.50	93	45	-3.71
Purchase of Property, Plant & Equipment	-4.43	-6.57	-2.68	-2.47	-10	-1.95	-2.09	-2.96	-2.68	-4.08	-4.28
Purchase of Investments	-215	-215	-40	-220	-115	-135	-150	-195	-89	-95	-58
Sale of Property, Plant & Equipment	-	-	-	0.03	0.00	-	0.15	-	0.00	0.07	0.02
Sale and/or Maturity of Investments	160	225	80	105	205	100	135	200	185	144	60
Other Investing Activities, net	-1.12	-	-0.72	-	-0.37	-1.45	-0.52	-0.54	0.00	-	-1.45
Net Cash From Financing Activities	-38	-48	-56	-54	-48	-34	-33	-39	-18	-0.28	-11
Net Cash From Continuing Financing Activities	-38	-48	-56	-54	-48	-34	-33	-39	-18	-0.28	-11
Repurchase of Preferred Equity	-	-	-	-	-0.32	-	0.83	-0.00	-	-	-0.02
Repurchase of Common Equity	-27	-36	-45	-43	-37	-21	-22	-17	-6.71	-0.17	-0.51
Payment of Dividends	-11	-11	-11	-11	-11	-11	-11	-21	-11	-	-11
Other Financing Activities, net	-0.17	-0.13	-0.11	-0.73	-0.11	-0.10	-0.93	-0.10	-0.45	0.22	-0.11
Effect of Exchange Rate Changes	1.25	-0.52	-0.39	0.97	-1.31	0.24	2.65	-1.17	-0.08	0.38	0.57
Cash Interest Paid	0.02	0.02	0.02	0.03	0.03	0.04	0.03	0.04	0.04	0.04	0.03
Cash Income Taxes Paid	0.26	17	5.05	0.25	0.89	17	3.63	2.25	-1.35	17	7.32

This table presents Kulicke and Soffa Industries' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	10/4/2025
Total Assets	904	982	1,171	1,186	1,080	1,055	1,602	1,589	1,500	1,240	1,104
Total Current Assets	707	781	953	987	894	860	1,352	1,332	1,189	995	902
Cash & Equivalents	499	424	392	321	364	188	363	556	529	227	216
Short-Term Investments	-	124	216	293	229	342	377	220	230	350	295
Note & Lease Receivable	109	130	198	243	196	199	421	309	159	194	184
Inventories, net	79	87	122	115	89	112	167	185	217	178	160
Prepaid Expenses	17	15	24	15	15	20	24	62	54	46	47
Plant, Property, & Equipment, net	53	50	68	76	72	59	68	81	110	65	59
Total Noncurrent Assets	144	151	150	122	113	135	182	176	201	180	144
Long-Term Investments	-	0.00	1.50	1.37	6.25	7.54	6.39	5.40	0.72	3.14	17
Goodwill	81	81	56	57	56	57	73	68	89	90	70
Intangible Assets	57	51	62	53	43	38	43	32	29	25	5.60
Noncurrent Deferred & Refundable Income Taxes	-	17	28	9.02	6.41	8.15	16	26	32	18	16
Other Noncurrent Operating Assets	5.12	2.26	2.06	2.59	2.49	25	44	45	50	44	36
Total Liabilities & Shareholders' Equity	904	982	1,171	1,186	1,080	1,055	1,602	1,589	1,500	1,240	1,104
Total Liabilities	135	183	251	306	311	297	506	394	325	296	283
Total Current Liabilities	74	126	193	174	175	158	352	249	182	184	188
Accounts Payable	26	42	51	49	37	58	155	67	49	59	57
Accrued Expenses	46	71	125	106	65	77	162	135	103	91	98
Current Deferred & Payable Income Tax Liabilities	2.44	13	17	20	12	18	31	40	23	26	27
Other Current Liabilities	-	-	-	0.00	61	5.90	4.90	6.77	6.57	7.72	6.18
Total Noncurrent Liabilities	61	57	58	131	136	139	155	145	144	112	95
Noncurrent Deferred Revenue	-	-	6.44	81	80	75	69	65	53	31	17
Noncurrent Deferred & Payable Income Tax Liabilities	34	27	27	26	32	33	33	34	37	35	36
Other Noncurrent Operating Liabilities	27	30	25	24	24	31	52	47	54	46	43
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	769	800	920	880	769	758	1,095	1,195	1,175	944	821
Total Preferred & Common Equity	769	800	920	880	769	758	1,095	1,195	1,175	944	821
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	769	800	920	880	769	758	1,095	1,195	1,175	944	821
Common Stock	492	499	507	519	534	539	550	562	578	597	620
Retained Earnings	403	443	569	614	595	616	949	1,342	1,356	1,243	1,200
Treasury Stock	-125	-139	-158	-249	-349	-395	-400	-676	-737	-882	-974
Accumulated Other Comprehensive Income / (Loss)	-1.10	-2.73	2.04	-3.90	-9.94	-2.52	-3.02	-33	-22	-13	-24

This table presents Kulicke and Soffa Industries' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	4/1/2023	7/1/2023	12/30/2023	3/30/2024	6/29/2024	12/28/2024	3/29/2025	6/28/2025	1/3/2026	4/4/2026	7/4/2026
Total Assets	1,524	1,508	1,487	1,299	1,257	1,251	1,145	1,125	1,115	1,186	1,319
Total Current Assets	1,189	1,183	1,178	1,050	1,013	1,014	948	930	914	982	1,105
Cash & Equivalents	389	402	425	360	367	278	287	246	282	338	369
Short-Term Investments	345	310	285	275	235	260	295	310	199	150	148
Note & Lease Receivable	169	198	184	195	200	248	174	174	216	256	329
Inventories, net	224	228	237	181	176	185	156	158	177	206	227
Prepaid Expenses	61	45	47	40	35	43	37	42	41	33	32
Plant, Property, & Equipment, net	111	114	107	65	65	62	60	60	57	58	66
Total Noncurrent Assets	224	212	202	183	180	175	137	135	143	146	148
Long-Term Investments	5.43	0.43	2.04	2.25	2.90	3.39	5.48	6.11	18	18	21
Goodwill	99	89	90	89	89	88	70	70	70	70	70
Intangible Assets	40	31	29	27	26	23	6.22	5.91	5.29	4.98	4.68
Noncurrent Deferred & Refundable Income Taxes	32	41	32	18	17	18	19	18	16	16	16
Other Noncurrent Operating Assets	48	49	49	47	45	43	37	36	34	37	37
Total Liabilities & Shareholders' Equity	1,524	1,508	1,487	1,299	1,257	1,251	1,145	1,125	1,115	1,186	1,319
Total Liabilities	340	338	325	287	284	279	281	287	290	328	407
Total Current Liabilities	196	197	181	166	166	169	183	188	197	234	321
Accounts Payable	55	53	59	51	52	49	48	53	69	85	117
Accrued Expenses	112	121	91	90	90	77	96	99	88	119	160
Current Deferred & Payable Income Tax Liabilities	21	17	25	17	17	36	32	30	34	23	38
Other Current Liabilities	7.27	6.57	6.70	7.02	7.13	7.05	6.70	6.57	5.89	6.19	6.08
Total Noncurrent Liabilities	145	142	144	121	118	110	98	99	93	95	86
Noncurrent Deferred Revenue	53	51	53	37	36	32	20	20	17	17	11
Noncurrent Deferred & Payable Income Tax Liabilities	36	37	37	36	36	35	35	36	36	35	34
Other Noncurrent Operating Liabilities	56	54	54	48	46	43	43	43	40	43	41
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,184	1,170	1,161	1,012	974	973	864	838	825	858	912
Total Preferred & Common Equity	1,184	1,170	1,161	1,012	974	973	864	838	825	858	912
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,184	1,170	1,161	1,012	974	973	864	838	825	858	912
Common Stock	567	572	578	585	591	598	605	612	620	627	634
Retained Earnings	1,350	1,343	1,354	1,240	1,241	1,313	1,218	1,204	1,206	1,230	1,277
Treasury Stock	-720	-728	-757	-794	-839	-914	-936	-957	-976	-976	-977
Accumulated Other Comprehensive Income / (Loss)	-13	-18	-14	-18	-20	-24	-23	-21	-25	-23	-22

This table displays calculated financial ratios and metrics derived from Kulicke and Soffa Industries' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/3/2015	10/1/2016	9/30/2017	9/29/2018	9/28/2019	10/3/2020	10/2/2021	10/1/2022	9/30/2023	9/28/2024	10/4/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.65%	16.91%	28.99%	9.90%	-39.26%	15.39%	143.54%	-0.93%	-50.62%	-4.88%	-7.38%
EBITDA Growth	-36.40%	21.92%	84.29%	43.53%	-77.42%	86.69%	452.42%	13.67%	-86.10%	-199.22%	121.77%
EBIT Growth	-49.87%	39.81%	109.60%	47.35%	-87.03%	170.75%	604.93%	13.97%	-91.61%	-334.54%	96.51%
NOPAT Growth	-18.38%	-9.28%	158.10%	-55.62%	-86.24%	548.72%	667.67%	16.93%	-92.69%	-307.42%	99.95%
Net Income Growth	-17.58%	-6.66%	160.24%	-55.05%	-79.44%	348.81%	602.03%	18.08%	-86.82%	-220.75%	100.31%
EPS Growth	-14.81%	-1.45%	157.35%	-54.29%	-77.50%	361.11%	596.39%	22.66%	-86.04%	-225.25%	100.32%
Operating Cash Flow Growth	6.57%	-22.15%	99.26%	-9.40%	-46.59%	43.12%	217.79%	30.05%	-55.56%	-82.10%	265.90%
Free Cash Flow Firm Growth	-143.59%	341.31%	-5.18%	57.98%	4.26%	-103.03%	7,720.37%	53.22%	-91.59%	-146.00%	598.32%
Invested Capital Growth	40.84%	-7.03%	23.04%	-14.50%	-35.91%	29.89%	58.43%	18.52%	0.18%	-12.24%	-19.22%
Revenue Q/Q Growth	-12.35%	4.44%	9.48%	-3.38%	-7.69%	6.47%	25.42%	-11.69%	-10.16%	-2.89%	-0.57%
EBITDA Q/Q Growth	-36.47%	1.97%	40.12%	-8.36%	-28.16%	24.10%	43.92%	-15.05%	-39.97%	-42.04%	-15.02%
EBIT Q/Q Growth	-47.21%	4.53%	47.70%	-9.39%	-43.86%	35.58%	46.96%	-15.66%	-54.93%	-22.17%	-126.56%
NOPAT Q/Q Growth	-26.50%	0.29%	31.69%	-17.87%	-71.47%	30.22%	47.81%	-14.43%	-58.51%	-22.17%	90.55%
Net Income Q/Q Growth	-25.92%	1.19%	30.61%	-16.98%	-66.60%	21.85%	47.32%	-13.70%	-42.10%	-19.46%	-96.42%
EPS Q/Q Growth	-24.18%	0.00%	31.58%	-16.67%	-64.00%	22.06%	46.70%	-11.93%	-42.11%	-19.23%	-94.29%
Operating Cash Flow Q/Q Growth	88.50%	-7.54%	33.49%	-23.76%	-41.54%	107.65%	43.98%	-1.72%	-18.39%	-59.65%	-17.57%
Free Cash Flow Firm Q/Q Growth	62.49%	-4.30%	-20.54%	0.29%	-30.87%	94.12%	66.96%	-3.49%	-58.42%	-139.22%	-25.20%
Invested Capital Q/Q Growth	-10.28%	-9.99%	5.83%	1.99%	23.71%	-2.72%	5.15%	-9.18%	-9.41%	-1.36%	6.86%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.96%	44.81%	47.23%	46.05%	47.14%	47.82%	45.92%	49.77%	48.30%	38.05%	42.49%
EBITDA Margin	10.73%	11.19%	15.99%	20.88%	7.76%	12.56%	28.48%	32.68%	9.20%	-9.59%	2.26%
Operating Margin	7.19%	8.60%	13.98%	18.74%	4.00%	9.39%	27.18%	31.26%	5.31%	-13.10%	-0.49%
EBIT Margin	7.19%	8.60%	13.98%	18.74%	4.00%	9.39%	27.18%	31.26%	5.31%	-13.10%	-0.49%
Profit (Net Income) Margin	9.68%	7.73%	15.59%	6.37%	2.16%	8.39%	24.19%	28.83%	7.70%	-9.77%	0.03%
Tax Burden Percent	132.95%	86.27%	106.40%	31.92%	33.59%	81.29%	88.57%	90.89%	79.15%	118.25%	1.04%
Interest Burden Percent	101.18%	104.10%	104.80%	106.55%	160.51%	109.96%	100.51%	101.47%	183.08%	63.09%	-635.11%
Effective Tax Rate	-32.95%	13.73%	-6.24%	68.01%	66.05%	18.65%	11.41%	9.11%	20.85%	0.00%	98.96%
Return on Invested Capital (ROIC)	22.17%	17.83%	42.81%	18.57%	3.38%	24.41%	128.34%	112.03%	7.54%	-16.64%	-0.01%
ROIC Less NNEP Spread (ROIC-NNEP)	22.06%	17.46%	41.79%	18.02%	2.67%	23.58%	128.07%	111.20%	4.17%	-16.01%	-0.05%
Return on Net Nonoperating Assets (RNNOA)	-15.51%	-11.65%	-28.15%	-12.27%	-1.97%	-17.56%	-88.72%	-74.16%	-2.71%	10.13%	0.03%
Return on Equity (ROE)	6.66%	6.18%	14.67%	6.30%	1.41%	6.85%	39.62%	37.87%	4.82%	-6.51%	0.02%
Cash Return on Invested Capital (CROIC)	-11.74%	25.11%	22.15%	34.20%	47.15%	-1.59%	83.13%	95.07%	7.36%	-3.60%	21.26%
Operating Return on Assets (OROA)	4.17%	5.72%	10.50%	14.14%	1.91%	5.48%	31.06%	29.47%	2.55%	-6.75%	-0.28%
Return on Assets (ROA)	5.62%	5.14%	11.71%	4.81%	1.03%	4.90%	27.65%	27.18%	3.70%	-5.04%	0.02%
Return on Common Equity (ROCE)	6.66%	6.18%	14.67%	6.30%	1.41%	6.85%	39.62%	37.87%	4.82%	-6.51%	0.02%
Return on Equity Simple (ROE_SIMPLE)	6.75%	6.06%	13.71%	6.44%	1.52%	6.90%	33.52%	36.29%	4.87%	-7.31%	0.00%
Net Operating Profit after Tax (NOPAT)	51	47	120	53	7.34	48	365	427	31	-65	-0.03
NOPAT Margin	9.56%	7.42%	14.85%	6.00%	1.36%	7.64%	24.08%	28.42%	4.20%	-9.17%	-0.01%
Net Nonoperating Expense Percent (NNEP)	0.11%	0.36%	1.03%	0.55%	0.71%	0.83%	0.28%	0.82%	3.37%	-0.64%	0.04%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	0.00%
Cost of Revenue to Revenue	53.04%	55.19%	52.77%	53.95%	52.86%	52.18%	54.08%	50.23%	51.70%	61.95%	57.51%
SG&A Expenses to Revenue	22.99%	21.48%	16.51%	13.86%	21.63%	18.62%	9.69%	9.31%	20.60%	23.44%	25.64%
R&D to Revenue	16.78%	14.73%	12.39%	13.45%	21.51%	19.81%	9.06%	9.10%	19.49%	21.41%	22.87%
Operating Expenses to Revenue	39.77%	36.21%	33.25%	27.31%	43.14%	38.43%	18.75%	18.51%	42.99%	51.15%	42.98%
Earnings before Interest and Taxes (EBIT)	39	54	113	167	22	59	412	470	39	-92	-3.22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	58	70	129	186	42	78	432	491	68	-68	15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.79	1.02	1.50	1.66	1.79	1.69	3.19	1.81	2.30	2.59	2.56
Price to Tangible Book Value (P/TBV)	0.96	1.23	1.72	1.90	2.05	1.94	3.56	1.98	2.56	2.94	2.82
Price to Revenue (P/Rev)	1.13	1.30	1.70	1.65	2.55	2.06	2.30	1.44	3.64	3.46	3.22
Price to Earnings (P/E)	11.66	16.89	10.93	25.81	118.04	24.55	9.50	5.00	47.25	0.00	9,875.82
Dividend Yield	0.00%	0.00%	0.00%	1.11%	2.21%	2.31%	0.99%	1.82%	1.59%	1.79%	2.03%
Earnings Yield	8.57%	5.92%	9.15%	3.87%	0.85%	4.07%	10.52%	20.01%	2.12%	0.00%	0.01%
Enterprise Value to Invested Capital (EV/IC)	0.39	1.08	2.48	3.20	4.58	3.39	7.86	3.35	4.68	5.11	5.36
Enterprise Value to Revenue (EV/Rev)	0.20	0.43	0.95	0.95	1.44	1.20	1.81	0.92	2.61	2.63	2.41
Enterprise Value to EBITDA (EV/EBITDA)	1.86	3.85	5.94	4.56	18.52	9.54	6.35	2.82	28.41	0.00	106.84
Enterprise Value to EBIT (EV/EBIT)	2.77	5.01	6.79	5.08	35.91	12.75	6.65	2.95	49.20	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	2.08	5.81	6.40	15.89	105.77	15.68	7.51	3.24	62.16	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	1.22	3.95	5.64	6.86	11.76	7.90	9.14	3.55	11.19	59.93	13.88
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	4.13	12.36	8.63	7.58	0.00	11.59	3.82	63.64	0.00	22.55
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.70	-0.67	-0.67	-0.68	-0.74	-0.74	-0.69	-0.67	-0.65	-0.63	-0.63
Leverage Ratio	1.19	1.20	1.25	1.31	1.37	1.40	1.43	1.39	1.30	1.29	1.33
Compound Leverage Factor	1.20	1.25	1.31	1.40	2.20	1.54	1.44	1.41	2.39	0.82	-8.43
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.88	4.94	5.76	5.63	4.79	4.99	7.51	7.22	7.64	7.46	7.34
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	9.57	6.20	4.94	5.67	5.12	5.45	3.84	5.36	6.55	5.41	4.79
Quick Ratio	8.21	5.39	4.18	4.92	4.52	4.62	3.30	4.36	5.06	4.20	3.69
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-27	66	62	98	102	-3.11	237	363	30	-14	70
Operating Cash Flow to CapEx	871.00%	1,324.43%	562.38%	621.50%	572.03%	809.08%	1,334.42%	1,711.05%	395.76%	192.53%	668.19%
Free Cash Flow to Firm to Interest Expense	-22.97	59.23	58.70	93.18	49.83	-1.81	1,085.61	0.00	0.00	0.00	521.50
Operating Cash Flow to Interest Expense	74.28	61.79	128.72	117.17	32.10	55.02	1,376.29	0.00	0.00	0.00	847.50
Operating Cash Flow Less CapEx to Interest Expense	65.75	57.13	105.83	98.32	26.49	48.22	1,273.16	0.00	0.00	0.00	720.66
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.66	0.75	0.75	0.48	0.58	1.14	0.94	0.48	0.52	0.56
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	4.42	4.16	4.08	4.04	2.79	3.23	5.88	4.29	1.91	2.21	2.23
Fixed Asset Turnover	10.12	12.11	13.70	12.36	7.28	9.48	23.88	20.20	7.78	8.08	10.57
Accounts Payable Turnover	9.38	10.28	9.17	9.61	6.70	6.89	7.73	6.81	6.58	8.09	6.48
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	82.61	87.72	89.47	90.25	130.74	112.87	62.07	85.13	191.27	164.80	163.97
Days Payable Outstanding (DPO)	38.90	35.50	39.82	38.00	54.49	52.98	47.22	53.63	55.45	45.12	56.29
Cash Conversion Cycle (CCC)	43.70	52.22	49.65	52.25	76.25	59.89	14.86	31.50	135.83	119.68	107.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	271	252	310	265	170	220	349	414	414	364	294
Invested Capital Turnover	2.32	2.40	2.88	3.10	2.49	3.20	5.33	3.94	1.79	1.82	1.99
Increase / (Decrease) in Invested Capital	78	-19	58	-45	-95	51	129	65	0.73	-51	-70
Enterprise Value (EV)	107	270	768	847	776	746	2,744	1,386	1,940	1,860	1,576
Market Capitalization	605	818	1,379	1,463	1,376	1,284	3,490	2,167	2,701	2,440	2,104
Book Value per Share	$10.53	$11.36	$12.94	$13.03	$12.13	$12.26	$17.67	$20.57	$20.80	$17.32	$15.75
Tangible Book Value per Share	$8.63	$9.48	$11.27	$11.41	$10.58	$10.73	$15.81	$18.85	$18.71	$15.21	$14.31
Total Capital	769	800	920	880	769	758	1,095	1,195	1,175	944	821
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-499	-548	-610	-616	-599	-538	-746	-781	-760	-580	-528
Capital Expenditures (CapEx)	10	5.17	24	20	12	12	22	23	44	16	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	135	107	151	199	126	172	260	308	248	234	203
Debt-free Net Working Capital (DFNWC)	633	655	760	813	719	702	1,000	1,083	1,008	811	713
Net Working Capital (NWC)	633	655	760	813	719	702	1,000	1,083	1,008	811	713
Net Nonoperating Expense (NNE)	-0.60	-1.91	-5.96	-3.36	-4.32	-4.70	-1.77	-6.29	-26	4.26	-0.25
Net Nonoperating Obligations (NNO)	-499	-548	-610	-616	-599	-538	-746	-781	-760	-580	-528
Total Depreciation and Amortization (D&A)	19	16	16	19	20	20	20	21	29	25	18
Debt-free, Cash-free Net Working Capital to Revenue	25.13%	17.07%	18.72%	22.39%	23.32%	27.63%	17.15%	20.47%	33.42%	33.14%	30.98%
Debt-free Net Working Capital to Revenue	118.07%	104.43%	93.99%	91.46%	133.16%	112.70%	65.89%	72.05%	135.69%	114.86%	109.06%
Net Working Capital to Revenue	118.07%	104.43%	93.99%	91.46%	133.16%	112.70%	65.89%	72.05%	135.69%	114.86%	109.06%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$1.78	$0.00	$0.00	$0.00	$5.92	$0.00	$1.01	($1.24)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	70.91M	0.00	0.00	0.00	62.01M	0.00	56.68M	55.61M	52.96M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$1.75	$0.00	$0.00	$0.00	$5.78	$0.00	$0.99	($1.24)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	72.06M	0.00	0.00	0.00	63.52M	0.00	57.55M	55.61M	53.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	70.60M	0.00	0.00	0.00	62.42M	0.00	56.72M	53.87M	52.36M
Normalized Net Operating Profit after Tax (NOPAT)	27	47	104	117	15	48	365	428	48	-34	-28
Normalized NOPAT Margin	5.04%	7.42%	12.83%	13.12%	2.80%	7.64%	24.08%	28.50%	6.50%	-4.76%	-4.22%
Pre Tax Income Margin	7.28%	8.95%	14.65%	19.97%	6.42%	10.32%	27.32%	31.72%	9.72%	-8.26%	3.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	32.62	48.74	106.78	158.09	10.52	34.10	1,891.96	0.00	0.00	0.00	-24.06
NOPAT to Interest Expense	43.37	42.05	113.44	50.58	3.57	27.74	1,676.11	0.00	0.00	0.00	-0.25
EBIT Less CapEx to Interest Expense	24.09	44.07	83.90	139.24	4.90	27.30	1,788.82	0.00	0.00	0.00	-150.90
NOPAT Less CapEx to Interest Expense	34.84	37.38	90.56	31.73	-2.04	20.94	1,572.97	0.00	0.00	0.00	-127.09
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	14.43%	270.88%	57.81%	9.11%	9.08%	73.56%	-64.00%	25,382.63%
Augmented Payout Ratio	145.85%	30.03%	14.43%	173.77%	1,128.15%	162.11%	11.95%	73.97%	194.66%	-282.52%	70,971.83%

This table displays calculated financial ratios and metrics derived from Kulicke and Soffa Industries' official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	10/4/2025	1/3/2026	4/4/2026	7/4/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	52,326,516.00	52,332,877.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	52,326,516.00	52,332,877.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.67	1.10
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.86%	-0.55%	-4.85%	-10.38%	-2.96%	-5.86%	-18.30%	-2.07%	20.17%	49.78%	122.63%
EBITDA Growth	-44.49%	-612.17%	222.23%	-72.71%	847.12%	18.87%	-116.47%	-34.63%	-76.24%	153.41%	3,419.66%
EBIT Growth	-85.68%	-932.65%	284.43%	-86.19%	5,018.07%	19.48%	-173.63%	-66.98%	-79.43%	145.55%	1,220.22%
NOPAT Growth	-85.53%	-898.15%	243.55%	-79.43%	5,495.46%	19.48%	-168.57%	-73.84%	-82.55%	153.80%	1,362.81%
Net Income Growth	-36.30%	-782.67%	194.74%	-48.12%	778.53%	17.69%	-126.82%	-47.36%	-79.43%	141.59%	1,845.70%
EPS Growth	-36.00%	-803.85%	214.29%	-48.78%	843.75%	13.11%	-127.27%	-33.33%	-78.81%	141.51%	1,883.33%
Operating Cash Flow Growth	-108.61%	-1,207.03%	199.65%	-59.20%	357.84%	496.45%	-72.56%	-76.58%	-147.26%	-87.14%	626.48%
Free Cash Flow Firm Growth	-382.47%	-184.92%	1,619.12%	260.04%	231.38%	938.37%	-5.74%	31.14%	24.80%	-210.34%	-151.15%
Invested Capital Growth	19.50%	-15.53%	-19.40%	-12.24%	-4.12%	-26.12%	-25.43%	-19.22%	-24.31%	26.93%	36.25%
Revenue Q/Q Growth	-15.39%	0.52%	5.57%	-0.18%	-8.38%	-2.49%	-8.38%	19.64%	12.43%	21.54%	36.18%
EBITDA Q/Q Growth	-64.92%	-1,114.55%	113.47%	-43.06%	1,117.61%	-186.90%	97.27%	326.05%	342.57%	95.34%	69.87%
EBIT Q/Q Growth	-91.31%	-6,311.16%	107.87%	-67.51%	3,122.35%	-197.71%	92.80%	114.57%	1,906.76%	116.42%	77.01%
NOPAT Q/Q Growth	-91.35%	-5,513.13%	108.45%	-48.06%	2,254.61%	-177.89%	92.80%	119.82%	1,470.92%	140.13%	68.93%
Net Income Q/Q Growth	-60.21%	-1,204.92%	111.94%	-1.20%	573.78%	-203.52%	96.11%	293.95%	163.30%	109.26%	63.36%
EPS Q/Q Growth	-60.98%	-1,243.75%	112.02%	-4.55%	619.05%	-205.30%	96.23%	333.33%	128.57%	106.25%	62.12%
Operating Cash Flow Q/Q Growth	-109.46%	-174.83%	233.50%	17.56%	-40.22%	322.58%	-90.76%	0.35%	-220.62%	214.98%	340.23%
Free Cash Flow Firm Q/Q Growth	-580.50%	93.58%	2,155.03%	-43.19%	75.34%	-59.04%	131.04%	-20.95%	66.86%	-136.21%	-7.11%
Invested Capital Q/Q Growth	8.47%	-16.54%	-1.72%	-1.36%	18.51%	-35.70%	-0.80%	6.86%	11.04%	7.83%	6.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.67%	9.57%	46.64%	48.34%	52.42%	24.93%	46.66%	45.74%	49.57%	49.34%	47.80%
EBITDA Margin	5.65%	-57.06%	7.28%	4.15%	55.18%	-49.17%	-1.47%	2.77%	10.91%	17.54%	21.87%
Operating Margin	0.99%	-61.11%	4.56%	1.48%	52.16%	-52.27%	-4.11%	0.50%	8.93%	15.90%	20.66%
EBIT Margin	0.99%	-61.11%	4.56%	1.48%	52.16%	-52.27%	-4.11%	0.50%	8.93%	15.90%	20.66%
Profit (Net Income) Margin	5.43%	-59.67%	6.75%	6.68%	49.15%	-52.18%	-2.22%	3.59%	8.41%	14.49%	17.38%
Tax Burden Percent	80.32%	106.60%	75.16%	120.17%	87.81%	106.88%	2,787.29%	95.19%	74.52%	82.68%	78.91%
Interest Burden Percent	683.40%	91.60%	197.14%	374.97%	107.30%	93.40%	1.94%	754.62%	126.48%	110.22%	106.58%
Effective Tax Rate	19.68%	0.00%	24.84%	-20.17%	12.19%	0.00%	0.00%	4.81%	25.48%	17.32%	21.09%
Return on Invested Capital (ROIC)	1.42%	-76.90%	6.03%	3.23%	72.94%	-77.52%	-5.88%	0.95%	12.08%	32.11%	47.70%
ROIC Less NNEP Spread (ROIC-NNEP)	0.37%	-72.68%	5.11%	1.91%	72.05%	-73.39%	-6.04%	-0.05%	11.40%	31.51%	47.06%
Return on Net Nonoperating Assets (RNNOA)	-0.24%	45.56%	-3.14%	-1.21%	-42.32%	47.88%	3.90%	0.03%	-6.60%	-20.00%	-29.59%
Return on Equity (ROE)	1.18%	-31.34%	2.89%	2.03%	30.62%	-29.64%	-1.98%	0.98%	5.48%	12.11%	18.12%
Cash Return on Invested Capital (CROIC)	-12.14%	1.72%	8.66%	-3.60%	3.96%	32.17%	29.03%	21.26%	14.35%	-11.23%	0.27%
Operating Return on Assets (OROA)	0.48%	-31.89%	2.40%	0.76%	26.71%	-29.56%	-2.27%	0.28%	5.19%	10.48%	16.07%
Return on Assets (ROA)	2.64%	-31.14%	3.55%	3.45%	25.17%	-29.51%	-1.22%	2.00%	4.89%	9.55%	13.51%
Return on Common Equity (ROCE)	1.18%	-31.34%	2.89%	2.03%	30.62%	-29.64%	-1.98%	0.98%	5.48%	12.11%	18.12%
Return on Equity Simple (ROE_SIMPLE)	4.47%	-6.51%	-5.93%	0.00%	0.34%	2.49%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1.36	-74	6.22	3.23	76	-59	-4.27	0.85	13	32	54
NOPAT Margin	0.79%	-42.78%	3.42%	1.78%	45.80%	-36.59%	-2.87%	0.48%	6.65%	13.14%	16.30%
Net Nonoperating Expense Percent (NNEP)	1.05%	-4.22%	0.92%	1.33%	0.89%	-4.13%	0.17%	1.00%	0.68%	0.60%	0.64%
Return On Investment Capital (ROIC_SIMPLE)	0.12%	-	-	-	7.82%	-6.86%	-0.51%	0.10%	1.61%	3.72%	5.91%
Cost of Revenue to Revenue	53.33%	90.43%	53.36%	51.66%	47.58%	75.07%	53.34%	54.26%	50.43%	50.66%	52.20%
SG&A Expenses to Revenue	24.18%	22.93%	21.20%	25.48%	23.24%	29.64%	26.68%	23.36%	20.42%	17.62%	13.85%
R&D to Revenue	21.50%	21.91%	20.88%	21.38%	22.76%	22.98%	24.08%	21.88%	20.23%	15.83%	13.29%
Operating Expenses to Revenue	45.68%	70.68%	42.09%	46.86%	0.52%	77.20%	50.76%	44.99%	40.64%	33.44%	27.14%
Earnings before Interest and Taxes (EBIT)	1.69	-105	8.28	2.69	87	-85	-6.09	0.89	18	39	68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	9.68	-98	13	7.53	92	-80	-2.18	4.92	22	43	72
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.62	2.79	2.80	2.59	2.65	2.04	2.19	2.56	3.07	3.91	6.96
Price to Tangible Book Value (P/TBV)	2.91	3.15	3.18	2.94	2.99	2.24	2.41	2.82	3.37	4.28	7.58
Price to Revenue (P/Rev)	4.12	3.83	3.75	3.46	3.67	2.55	2.79	3.22	3.68	4.36	6.68
Price to Earnings (P/E)	58.57	0.00	0.00	0.00	769.64	82.07	308.14	9,875.82	0.00	60.93	54.86
Dividend Yield	1.43%	1.56%	1.61%	1.79%	1.69%	2.45%	2.35%	2.03%	1.70%	1.28%	0.68%
Earnings Yield	1.71%	0.00%	0.00%	0.00%	0.13%	1.22%	0.32%	0.01%	0.00%	1.64%	1.82%
Enterprise Value to Invested Capital (EV/IC)	5.17	5.83	5.76	5.11	4.71	4.25	4.62	5.36	6.23	8.09	15.52
Enterprise Value to Revenue (EV/Rev)	3.15	2.97	2.92	2.63	2.90	1.70	1.93	2.41	2.96	3.71	6.12
Enterprise Value to EBITDA (EV/EBITDA)	38.41	0.00	0.00	0.00	142.81	35.96	73.24	106.84	0.00	42.46	41.07
Enterprise Value to EBIT (EV/EBIT)	79.34	0.00	0.00	0.00	0.00	90.97	0.00	0.00	0.00	55.63	46.30
Enterprise Value to NOPAT (EV/NOPAT)	100.11	0.00	0.00	0.00	0.00	170.45	0.00	0.00	0.00	72.41	57.81
Enterprise Value to Operating Cash Flow (EV/OCF)	28.72	37.05	27.61	59.93	35.47	7.49	9.23	13.88	23.71	176.59	105.45
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	309.85	59.39	0.00	116.59	11.23	13.61	22.55	37.41	0.00	6,539.34
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.65	-0.63	-0.61	-0.63	-0.59	-0.65	-0.64	-0.63	-0.58	-0.63	-0.63
Leverage Ratio	1.30	1.29	1.29	1.29	1.28	1.30	1.32	1.33	1.32	1.35	1.40
Compound Leverage Factor	8.87	1.18	2.54	4.85	1.38	1.22	0.03	10.02	1.66	1.49	1.49
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	8.18	8.36	8.56	7.71	8.61	6.42	6.69	7.35	8.20	9.09	12.32
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.50	6.34	6.10	5.41	5.99	5.18	4.94	4.79	4.64	4.21	3.44
Quick Ratio	4.93	5.01	4.83	4.20	4.65	4.13	3.88	3.69	3.54	3.18	2.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-72	-4.62	95	54	95	39	90	71	118	-43	-46
Operating Cash Flow to CapEx	-165.63%	-306.62%	1,002.50%	1,295.33%	185.28%	4,087.87%	379.83%	250.46%	-333.94%	256.58%	1,061.66%
Free Cash Flow to Firm to Interest Expense	-3,273.01	-256.75	0.00	0.00	3,503.81	0.00	2,797.41	0.00	2,951.66	-1,155.41	-1,346.71
Operating Cash Flow to Interest Expense	-333.23	-1,119.33	0.00	0.00	700.07	0.00	230.63	0.00	-223.33	277.59	1,329.88
Operating Cash Flow Less CapEx to Interest Expense	-534.41	-1,484.39	0.00	0.00	322.22	0.00	169.91	0.00	-290.20	169.41	1,204.62
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.49	0.52	0.53	0.52	0.51	0.57	0.55	0.56	0.58	0.66	0.78
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	1.73	2.25	2.23	2.21	2.02	2.33	2.24	2.23	2.20	2.21	2.55
Fixed Asset Turnover	7.37	8.38	8.17	8.08	8.26	11.05	10.60	10.57	11.47	13.02	15.11
Accounts Payable Turnover	6.67	8.54	8.58	8.09	7.90	7.83	7.12	6.48	6.75	5.96	5.81
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	211.03	162.58	163.55	164.80	180.95	156.83	163.15	163.97	165.88	165.51	142.86
Days Payable Outstanding (DPO)	54.70	42.72	42.56	45.12	46.20	46.59	51.25	56.29	54.08	61.20	62.87
Cash Conversion Cycle (CCC)	156.33	119.86	120.99	119.68	134.75	110.24	111.90	107.68	111.81	104.31	79.99
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	450	375	369	364	431	277	275	294	326	352	375
Invested Capital Turnover	1.79	1.80	1.76	1.82	1.59	2.12	2.04	1.99	1.82	2.44	2.93
Increase / (Decrease) in Invested Capital	73	-69	-89	-51	-19	-98	-94	-70	-105	75	100
Enterprise Value (EV)	2,325	2,186	2,123	1,860	2,031	1,178	1,271	1,576	2,033	2,847	5,812
Market Capitalization	3,037	2,823	2,728	2,440	2,573	1,765	1,834	2,104	2,532	3,353	6,350
Book Value per Share	$20.50	$17.97	$17.55	$17.32	$18.06	$16.19	$15.87	$15.75	$15.76	$16.39	$17.43
Tangible Book Value per Share	$18.41	$15.90	$15.49	$15.21	$15.99	$14.77	$14.44	$14.31	$14.33	$14.96	$16.01
Total Capital	1,161	1,012	974	944	973	864	838	821	825	858	912
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-712	-637	-605	-580	-542	-587	-563	-528	-499	-506	-537
Capital Expenditures (CapEx)	4.43	6.57	2.68	2.44	10	1.95	1.94	2.96	2.68	4.00	4.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	287	250	245	234	306	184	185	203	236	261	268
Debt-free Net Working Capital (DFNWC)	996	885	847	811	845	765	742	713	717	749	784
Net Working Capital (NWC)	996	885	847	811	845	765	742	713	717	749	784
Net Nonoperating Expense (NNE)	-7.93	29	-6.04	-8.89	-5.55	25	-0.98	-5.53	-3.52	-3.26	-3.55
Net Nonoperating Obligations (NNO)	-712	-637	-605	-580	-542	-587	-563	-528	-499	-506	-537
Total Depreciation and Amortization (D&A)	7.99	6.97	4.94	4.84	5.01	5.01	3.92	4.03	3.96	3.98	4.00
Debt-free, Cash-free Net Working Capital to Revenue	38.88%	33.94%	33.72%	33.14%	43.70%	26.57%	28.16%	30.98%	34.35%	33.97%	28.16%
Debt-free Net Working Capital to Revenue	135.11%	120.12%	116.48%	114.86%	120.48%	110.72%	112.75%	109.06%	104.33%	97.47%	82.53%
Net Working Capital to Revenue	135.11%	120.12%	116.48%	114.86%	120.48%	110.72%	112.75%	109.06%	104.33%	97.47%	82.53%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.16	($1.83)	$0.22	$0.21	$1.52	($1.59)	($0.06)	$0.13	$0.32	$0.67	$1.10
Adjusted Weighted Average Basic Shares Outstanding	56.65M	56.15M	55.28M	55.61M	53.79M	53.31M	52.69M	52.96M	52.32M	52.33M	52.33M
Adjusted Diluted Earnings per Share	$0.16	($1.83)	$0.22	$0.21	$1.51	($1.59)	($0.06)	$0.14	$0.32	$0.66	$1.07
Adjusted Weighted Average Diluted Shares Outstanding	57.02M	56.15M	55.72M	55.61M	54.21M	53.31M	52.69M	53.19M	52.52M	53.12M	53.43M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.34M	55.46M	54.51M	53.87M	53.38M	52.77M	52.15M	52.36M	52.33M	52.33M	52.33M
Normalized Net Operating Profit after Tax (NOPAT)	1.36	-42	6.22	1.88	9.36	-31	-4.27	0.85	13	32	54
Normalized NOPAT Margin	0.79%	-24.69%	3.42%	1.04%	5.64%	-19.38%	-2.87%	0.48%	6.65%	13.14%	16.30%
Pre Tax Income Margin	6.76%	-55.98%	8.98%	5.56%	55.97%	-48.82%	-0.08%	3.77%	11.29%	17.52%	22.02%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	76.95	-5,841.94	0.00	0.00	3,209.22	0.00	-190.44	0.00	445.50	1,042.32	2,007.82
NOPAT to Interest Expense	61.81	-4,089.36	0.00	0.00	2,818.07	0.00	-133.31	0.00	331.99	861.83	1,584.38
EBIT Less CapEx to Interest Expense	-124.23	-6,207.00	0.00	0.00	2,831.37	0.00	-251.16	0.00	378.63	934.14	1,882.56
NOPAT Less CapEx to Interest Expense	-139.37	-4,454.42	0.00	0.00	2,440.22	0.00	-194.03	0.00	265.11	753.64	1,459.12
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	82.94%	-66.06%	-76.02%	-64.00%	1,323.54%	204.29%	733.52%	25,382.63%	-83.55%	78.15%	37.02%
Augmented Payout Ratio	179.60%	-188.48%	-278.10%	-282.52%	6,132.93%	882.31%	2,796.30%	70,971.83%	-186.57%	160.82%	58.10%

Financials Breakdown Chart

Key Financial Trends

Kulicke & Soffa Industries (NASDAQ: KLIC) has shown a strong operating recovery through the first three quarters of fiscal 2026. Revenue increased from $199.6 million in Q1 to $242.6 million in Q2 and $330.4 million in Q3. Q3 revenue was up approximately 123% year over year from the restated Q3 2025 figure of $148.4 million.

Profitability has improved sharply alongside the revenue recovery. Q3 2026 gross profit was $157.9 million, representing a gross margin of approximately 47.8%, while operating income reached $68.3 million, compared with a $6.1 million operating loss in Q3 2025. Net income rose to $57.4 million, or $1.07 per diluted share, versus a $3.3 million loss, or negative $0.06 per diluted share, in the year-ago quarter.

The balance sheet remains well capitalized, although its composition has changed. Cash and equivalents totaled $368.6 million at the end of Q3 2026, while short-term and long-term investments added another $168.8 million. Total current assets increased to $1.10 billion, producing a current ratio of approximately 3.4 times. However, total liabilities have increased as revenue has recovered, and a larger portion of current assets is tied up in receivables and inventory.

Cash generation also improved in Q3. Operating cash flow was $45.2 million, up from $10.3 million in Q2 and negative $8.9 million in Q1. Still, operating assets and liabilities reduced Q3 operating cash flow by $27.2 million, indicating that working-capital needs remain an important factor for investors to monitor.

Revenue momentum is accelerating: Quarterly revenue increased sequentially by approximately 21.5% in Q2 and 36.2% in Q3, while Q3 revenue more than doubled year over year.
Profitability has recovered: Q3 operating income reached $68.3 million, compared with operating losses in the restated Q3 2025 and Q2 2025 periods.
Strong earnings growth: Q3 net income increased to $57.4 million from a $3.3 million loss a year earlier, and diluted EPS improved to $1.07 from negative $0.06.
Operating cash flow turned meaningfully stronger: Cash flow from operations rose to $45.2 million in Q3 2026 from $7.4 million in Q3 2025, supporting internally funded operations and shareholder returns.
Liquidity remains substantial: KLIC had $368.6 million of cash, $148.0 million of short-term investments and $20.8 million of long-term investments at the latest quarter-end. The statements also show no conventional borrowings or interest-bearing debt line.
Shareholder distributions continue: The company paid $10.7 million in dividends and repurchased approximately $0.5 million of common stock in Q3, following larger repurchases in earlier periods.
Investment activity materially affects cash balances: KLIC routinely buys and sells large short-term investment positions. These transactions can make quarterly investing cash flow and reported cash changes appear more volatile than underlying operations.
Research and development spending remains elevated: Q3 research and development expense was $43.9 million, or roughly 13% of revenue. This supports product development but limits near-term operating leverage.
Working capital remains a cash-flow drag: Changes in operating assets and liabilities reduced Q3 operating cash flow by $27.2 million, following larger outflows of $36.2 million in Q2 and $38.0 million in Q1.
Receivables and inventory have risen sharply: Note and lease receivables reached $329.5 million and inventory increased to $227.1 million in Q3 2026, up substantially from Q3 2025. These balances could constrain cash flow if collections slow or demand weakens.

Overall, KLIC’s statements point to a powerful cyclical rebound in revenue, margins, earnings and operating cash flow. The company’s cash-rich balance sheet provides financial flexibility, but investors should watch whether the recovery converts into sustained free cash flow without continued increases in receivables and inventory. The historical data also shows that KLIC’s earnings can be highly cyclical, with prior periods including significant impairment charges and substantial losses.

09/18/26 08:59 PM ETAI Generated. May Contain Errors.

Kulicke and Soffa Industries Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Kulicke and Soffa Industries' financial year ends in October. Their financial year 2025 ended on October 4, 2025.

Over the last 10 years, Kulicke and Soffa Industries' net income changed from $51.91 million in 2015 to $213 thousand in 2025, a change of -99.6%. See Kulicke and Soffa Industries' forecast for analyst expectations on what's next for the company.

Kulicke and Soffa Industries' total operating income in 2025 was -$3.22 million, based on the following breakdown:

Total Gross Profit: $277.92 million
Total Operating Expenses: $281.15 million

Over the last 10 years, Kulicke and Soffa Industries' total revenue changed from $536.47 million in 2015 to $654.08 million in 2025, a change of 21.9%.

Kulicke and Soffa Industries' total liabilities were at $282.85 million at the end of 2025, a 4.5% decrease from 2024, and a 109.2% increase since 2015.

In the past 10 years, Kulicke and Soffa Industries' cash and equivalents has ranged from $188.13 million in 2020 to $555.54 million in 2022, and is currently $215.71 million as of their latest financial filing in 2025.

Over the last 10 years, Kulicke and Soffa Industries' book value per share changed from 10.53 in 2015 to 15.75 in 2025, a change of 49.6%.

Related Companies

Financial statements for NASDAQ:KLIC last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kulicke and Soffa Industries (KLIC) Financials

Financials Breakdown Chart

Key Financial Trends

Kulicke and Soffa Industries Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kulicke and Soffa Industries (KLIC) Financials

Annual Income Statements for Kulicke and Soffa Industries

Quarterly Income Statements for Kulicke and Soffa Industries

Annual Cash Flow Statements for Kulicke and Soffa Industries

Quarterly Cash Flow Statements for Kulicke and Soffa Industries

Annual Balance Sheets for Kulicke and Soffa Industries

Quarterly Balance Sheets for Kulicke and Soffa Industries

Annual Metrics And Ratios for Kulicke and Soffa Industries

Quarterly Metrics And Ratios for Kulicke and Soffa Industries

Financials Breakdown Chart

Key Financial Trends

Kulicke and Soffa Industries Financials - Frequently Asked Questions

When does Kulicke and Soffa Industries' fiscal year end?

How has Kulicke and Soffa Industries' net income changed over the last 10 years?

What is Kulicke and Soffa Industries' operating income?

How has Kulicke and Soffa Industries' revenue changed over the last 10 years?

How much debt does Kulicke and Soffa Industries have?

How much cash does Kulicke and Soffa Industries have?

How has Kulicke and Soffa Industries' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools